Losing weight on a GLP-1: how do you keep track of strength?

Can GLP-1 weight loss include muscle loss?

Yes—it can. Usually, most of the weight lost with a GLP-1 medicine is fat, but some can be muscle, water, and other tissue. A bathroom scale cannot tell the difference.

This is not a reason to fear the medicine or dismiss the benefits of losing weight. It is a reason to protect strength from the beginning. The goal is to improve health while keeping enough strength for stairs, carrying, recovery, and the years ahead.

What research shows about GLP-1 medicines and muscle

In one body-scan study of tirzepatide, about three-quarters of the weight lost was fat and about one-quarter was lean tissue. Lean tissue includes muscle, water, organs, and other tissue. The scan could not tell us that one-quarter of the weight lost was muscle.

Some loss of muscle can happen during substantial weight loss, with or without medicine. Age, starting strength, how quickly weight comes off, how little a person is able to eat, illness, and physical activity can all matter.

A 2025 advisory from four medical and nutrition organizations notes that adding protein without strength training may not be enough to protect muscle. Adequate protein and a safe strength-training plan work together to support muscle.

These medicines can do more than lower the number on a scale, but the heart evidence is specific. Semaglutide lowered the combined chance of a heart attack, stroke, or death from heart disease in adults who already had heart or blood-vessel disease and also had overweight or obesity.

In 2026, Mounjaro was approved to lower these events in adults with type 2 diabetes who are at high risk. It was at least as effective as dulaglutide, an older GLP-1 medicine already proven to lower heart events. It was not proven better. Zepbound contains the same ingredient but does not carry this heart-event approval. The exact product and the reason it is prescribed matter.

Stopping deserves its own plan. In an extension of a semaglutide trial, participants regained about two-thirds of their prior weight loss during the year after treatment ended. A tirzepatide withdrawal trial also found substantial regain after people were switched off treatment. These are group averages, not a prediction for one woman. They show why maintenance should be discussed before the last dose, not after it.

You do not need a body scan to notice whether something important is changing. Watch what your body can do. Are stairs, carrying groceries, getting up from a chair, or the strength exercises you normally do becoming easier, staying steady, or getting harder?

A smaller body can make movement feel easier because there is less weight to carry. That does not automatically mean the muscles became stronger. Follow both: how your body feels and what it can do.

If nausea, vomiting, constipation, or a very low appetite makes it difficult to eat or drink, tell the prescriber. Protecting strength becomes harder when the medicine makes adequate food or fluids difficult.

The right food and exercise plan depends on your health, medicines, kidney function, starting fitness, and what you can safely do. There is no single protein number or workout that is right for every woman.

• Track one or two familiar tasks: getting up from a chair without your hands, the weights and repetitions you can manage, stairs, or lifting a suitcase.
• Tell your clinician about new balance trouble, falls, dizziness, or a clear drop in what you can do. Muscle loss is not the only possible cause.
• Discuss how much protein fits your health and appetite instead of relying on a social-media number.
• Discuss safe strength training alongside adequate protein; adding protein alone may not preserve muscle.
• Know the exact medicine and source. A compounded drug is not an FDA-approved generic version.
• Talk about the maintenance or stopping plan while treatment is working.

What we do not know about long-term strength and bone

We still cannot tell from pounds alone how much muscle one woman is losing. We also do not have one proven protein target, strength plan, or monitoring schedule that fits everyone taking these medicines.

Most weight-loss studies were not designed to show whether women kept their strength and independence 10 or 20 years later. That is why it helps to notice what you can do now, as well as what you weigh.

Women made up about three-quarters of two major body-scan studies. But the studies did not look at women in menopause as their own group. We still do not know whether menopause changes the balance of fat and other tissue lost.

Bone deserves a careful answer too. Some studies have found bone-density loss during substantial medicine-assisted weight loss. In another trial, exercise helped protect hip and spine bone density better than medicine alone. We do not yet know the long-term fracture effect for every medicine or every woman.

That does not mean every woman taking a GLP-1 medicine needs a bone scan. It means a history of menopause, fractures from a minor fall, low bone density, steroid use, or frequent falls belongs in the conversation.

Why muscle and strength matter to heart health

Muscle helps your body use blood sugar. It helps you move, recover, and stay independent. Your heart delivers blood and oxygen. Your muscles turn that delivery into stairs climbed, groceries carried, and years lived with more capacity.

Weight loss may improve blood pressure, blood sugar, sleep apnea, and other parts of heart health for some people. The heart goal is not only to weigh less. It is to improve health while keeping enough strength for the life ahead.

After menopause, strength training may support heart health too

You may start lifting because you want to stay strong. Your blood pressure may benefit too.

A 2026 review included 60 studies of strength training in women after menopause. In the studies researchers could combine, strength training was linked with modest improvements in blood pressure and resting heart rate.

The authors described the average effect as moderate for the top blood-pressure number and for average pressure across a heartbeat, and small for the lower number and resting heart rate.

Not every study measured every result: 18 contributed data on the top blood-pressure number and 12 on resting heart rate. The researchers also found important weaknesses in how the randomized studies were conducted or reported. The findings are encouraging, but less certain. They do not prove that lifting prevents heart attacks.

Some studies suggested benefits for how blood vessels work and how the nervous system helps regulate heart rate, but those results were less consistent. A small number of heart-ultrasound studies found no harmful changes in heart structure in the programs studied. That is reassuring within those limits—not a guarantee that every workout is safe for every woman.

That belongs in the weight-loss conversation too. If you are taking a GLP-1 medicine, ask how your plan will support strength and what your body can do as your weight changes. This is a practical application of the research; the review did not show whether the same heart benefits occur specifically in women taking GLP-1 medicines.

One question to ask about GLP-1 treatment

While this medicine helps my weight, what should we do now to protect my strength and plan for maintenance later?